Skip to main content
OpenTrials
Completed

NCT Number: NCT04775472

Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation

The use of venoarterial-extracorporeal membrane oxygenation(VA-ECMO) was associated with lower in-hospital mortality in patients with cardiogenic shock. However, VA-ECMO has a deleterious effect for hemodynamics. It can increase left ventricular end-diastolic pressure(LVEDP), followed by left ventricular dilatation, abnormal opening of aortic valve and jeopardizes of myocardial recovery. Therefore, several methods have been used to reduce LVEDP. Among these, left atrial septostomy is effective, but less invasive than surgical left ventricular unloading. However, there is few data regarding this issue. Therefore, the investigators will evaluate the effect of routine, early left atrial septostomy in patients with VA-ECMO for the treatment of cardiogenic shock.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chonnam National University Hospital

Gwangju, South Korea

About this study

Study Objectives:

To determine the effect of early left atrial septostomy versus conventional approach(left atrial septostomy only in cases of significant changes due to left ventricular end-diastolic pressure increase) in patients who received venoarterial-extracorporeal membrane oxygenation(VA-ECMO) for the treatment of cardiogenic shock.

Study Background:

Cardiogenic shock is due to myocardial dysfunction from multifactorial causes, which has high mortality. The treatment for cardiogenic shock includes early coronary revascularization, inotropes, vasopressors, or mechanical circulatory support, such as intraaortic balloon pump(IABP), VA-ECMO. However, the routine use of IABP is not recommended for the treatment of cardiogenic shock in recent guidelines. VA-ECMO can be easily implanted, and can maintain high cardiac output. In several studies, The use of VA-ECMO was associated with lower in-hospital mortality in patients with cardiogenic shock.

However, VA-ECMO has a deleterious effect for hemodynamics. It can increase left ventricular end-diastolic pressure(LVEDP), followed by left ventricular dilatation, abnormal opening of aortic valve and jeopardizes of myocardial recovery. Therefore, several methods have been used to reduce LVEDP. Among these, left atrial septostomy is effective, but less invasive than surgical left ventricular unloading. However, there is few data regarding this issue. Therefore, the investigators will evaluate the effect of routine, early left atrial septostomy in patients with VA-ECMO for the treatment of cardiogenic shock.

Study Hypothesis:

Early, routine left atrial septostomy for left heart unloading is superior compared to conventional approach to reduce in-hospital mortality and the duration of VA-ECMO.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age more than 18 years old 2) Cardiogenic shock* 3) Successful VA-ECMO implantation
  • The definition of cardiogenic shock All these criteria should be met
  • Systolic blood pressure < 90 mmHg for 30 minutes, or needing inotrope or vasopressor to maintain systolic blood pressure > or = 90 mmHg
  • Pulmonary congestion on chest X-ray or increased left ventricular filling pressure by cardiac catheterization
  • At least one criteria of organ dysfunction
  • mental obtundation, clammy skin, oliguria, renal dysfunction, increased level of blood lactate

Exclusion criteria

<!-- -->

  • VA-ECMO after open heart surgery
  • VA-ECMO for the treatment of non-cardiac shock
  • Severe bleeding*
  • Terminal malignancy
  • Irreversible brain damage
  • Pregnancy or lactation
  • The definition of severe bleeding Hemoglobin decrease after VA-ECMO or cannulation site bleeding is not a exclusion criteria
  • Hypovolemic shock due to definite bleeding cause
  • Identifiable bleeding causes: gastrointestinal bleeding, hemothorax, traumatic bleeding, central nervous system hemorrhage, pulmonary hemorrhage

Treatment and study plan

Early left atrial septostomy within 12 hours after VA-ECMO implantation

Procedure

Early left atrial septostomy group will routinely receive left atrial septostomy within 12 hours after VA-ECMO implantation. Left atrial septostomy will be done using percutaneous technique.

Selective left atrial septostomy

Procedure

Left atrial septostomy will be done in cases of deleterious effect of increased LVEDP after VA-ECMO implantation, such as refractory pulmonary edema, abnormal opening of aortic valve, left ventricular dilatation, refractory ventricular tachycardia or fibrillation.

Primary outcomes

  1. Cumulative incidence rate of all-cause death

    Time frame: Up to 30 days

    Cumulative incidence rate of all-cause death

Secondary outcomes

  1. Rate of all-cause death or left atrial septostomy in conventional approach group

    Time frame: Up to 30 days

    Rate of all-cause death or left atrial septostomy in conventional approach group

  2. Rate of left atrial septostomy in conventional approach group

    Time frame: Up to 30 days

    Rate of left atrial septostomy in conventional approach group

  3. Incidence rate of all-cause death during index admission

    Time frame: Up to 6 months

    Incidence rate of all-cause death during index admission

  4. Cumulative incidence rate of cardiac death

    Time frame: Up to 30 days

    Cumulative incidence rate of cardiac death

  5. Cumulative incidence rate of non-cardiac death

    Time frame: Up to 30 days

    Cumulative incidence rate of non-cardiac death

  6. Weaning rate from venoarterial extracorporeal membrane oxygenation during index admission

    Time frame: Up to 6 months

    Weaning rate from venoarterial extracorporeal membrane oxygenation during index admission

  7. Rate of disappearance of pulmonary edema on chest X-ray during index admission

    Time frame: Up to 6 months

    Rate of disappearance of pulmonary edema on chest X-ray during index admission

  8. Weaning rate from mechanical ventilator during index admission

    Time frame: Up to 6 months

    Weaning rate from mechanical ventilator during index admission

  9. Intensive care unit length of stay during index admission

    Time frame: Up to 6 months

    Intensive care unit length of stay during index admission

  10. Hospital length of stay

    Time frame: Up to 6 months

    Hospital length of stay

  11. Lactate normalization rate

    Time frame: Up to 30 days

    Lactate normalization rate

  12. Lactate clearance rate

    Time frame: Up to 30 days

    Lactate clearance rate

  13. Rate of renal replacement therapy during index admission

    Time frame: Up to 6 months

    Rate of renal replacement therapy during index admission

  14. Rate of limb ischemia during index admission

    Time frame: Up to 6 months

    Rate of limb ischemia during index admission

  15. Rate of infection during index admission

    Time frame: Up to 6 months

    Rate of infection during index admission

  16. Rate of transient ischemic attack or stroke during index admission

    Time frame: Up to 6 months

    Rate of transient ischemic attack or stroke during index admission

  17. Rate of BARC bleeding type 3 or 5 during index admission

    Time frame: Up to 6 months

    Rate of BARC bleeding type 3 or 5 during index admission

  18. Rate of bridge to ventricular assist device or heart transplantation during index admission

    Time frame: Up to 6 months

    Rate of bridge to ventricular assist device or heart transplantation during index admission

  19. Rate of major vascular injury or cardiac tamponade during left atrial septostomy

    Time frame: Up to 30 days

    Rate of major vascular injury or cardiac tamponade during left atrial septostomy

  20. Cumulative incidence rate of all-cause death

    Time frame: Up to 12 months

    Cumulative incidence rate of all-cause death

  21. Cumulative incidence rate of cardiac death

    Time frame: Up to 12 months

    Cumulative incidence rate of cardiac death

  22. Cumulative incidence rate of non-cardiac death

    Time frame: Up to 12 months

    Cumulative incidence rate of non-cardiac death

  23. Re-hospitalization rate due to heart failure

    Time frame: Up to 12 months

    Re-hospitalization rate due to heart failure

  24. All-cause death or re-hospitalization rate due to heart failure

    Time frame: Up to 12 months

    All-cause death or re-hospitalization rate due to heart failure

Sponsors and collaborators

Lead sponsor

Chonnam National University Hospital

Other

Registry information

Official study title

Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Controlled Study

Acronym: EARLY-UNLOAD

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Mar 1, 2021
Registry last updated
Jan 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.